-       Report 
- October 2025
-  182 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- January 2025
-  83 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
            -       Report 
- August 2025
-  144 Pages 
- Global 
   From       €3155EUR$3,528USD£2,775GBP 
      €3712EUR$4,150USD£3,265GBP 
            -       Report 
- August 2025
-  148 Pages 
- Global 
   From       €3155EUR$3,528USD£2,775GBP 
      €3712EUR$4,150USD£3,265GBP 
            -       Report 
- August 2025
-  193 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
             -       Report 
- August 2025
-  182 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  550 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  381 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
            -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- March 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- August 2025
-  194 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  461 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
            -       Clinical Trials 
- April 2025
-  80 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
          -       Report 
- May 2025
-  120 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- July 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- August 2025
-  138 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- February 2025
-  182 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
          -       Report 
- June 2025
-  150 Pages 
- Global 
   From       €2414EUR$2,699USD£2,124GBP 
       
      Benzoyl Peroxide is a common active ingredient in acne drugs, used to treat mild to moderate acne. It works by killing bacteria that cause acne, reducing inflammation, and preventing the formation of new acne lesions. It is available in a variety of forms, including creams, gels, lotions, and washes. It is often used in combination with other acne treatments, such as antibiotics or retinoids. Benzoyl Peroxide is generally well tolerated, but can cause skin irritation and dryness.
The Benzoyl    Peroxide market is highly competitive, with many companies offering products containing the active ingredient. Some of the major players in the market include Galderma, GlaxoSmithKline, Johnson & Johnson, and Stiefel Laboratories. Other companies include Allergan, Aqua Pharmaceuticals, and Bayer. Show Less   Read more